Cargando…
Translating Molecular Profiling of Soft Tissue Sarcomas into Daily Clinical Practice
Soft tissue sarcomas are a group of rare mesenchymal tumors with more than 70 subtypes described. Treatment of these subtypes in an advanced setting is mainly according to a one-size-fits-all strategy indicating a high unmet need of new and more targeted therapeutic options in order to optimize surv...
Autores principales: | Jacobs, Celine, Lapeire, Lore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999686/ https://www.ncbi.nlm.nih.gov/pubmed/33799327 http://dx.doi.org/10.3390/diagnostics11030512 |
Ejemplares similares
-
Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
por: Fischer, Suzanne, et al.
Publicado: (2023) -
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial
por: Italiano, Antoine, et al.
Publicado: (2021) -
A review of soft-tissue sarcomas: translation of biological advances into treatment measures
por: Hoang, Ngoc T, et al.
Publicado: (2018) -
Cytogenetics and Molecular Genetics of Myxoid Soft-Tissue Sarcomas
por: Nishio, Jun, et al.
Publicado: (2011) -
Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib
por: Rajendra, Rajeev, et al.
Publicado: (2013)